secwatch.observer — SEC 8-K summary
======================================

Issuer:     Citius Pharmaceuticals, Inc. (CTXR)
CIK:        0001506251
Form:       8-K
Filed at:   2024-11-18T23:59:59+00:00
Accession:  0001213900-24-099649
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Citius Pharma raises $3M in registered direct offering of 12M shares and 12M warrants
--------------------------------------------------------------------------------

- Offering consists of 12M common shares and warrants for 12M shares at combined $0.25; gross proceeds $3.0M.
- Net proceeds approx. $2.7M after fees; intended for R&D, working capital, and general corporate purposes.
- Warrants exercisable at $0.25 per share, immediately exercisable, expire in 5 years; cashless exercise if no effective registration.
- Placement agent H.C. Wainwright receives 7% cash fee plus 840,000 placement agent warrants at $0.3125 per share.
- Closing occurred November 18, 2024; offering made under existing effective shelf registration (File No. 333-277319).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506251/000121390024099649/0001213900-24-099649-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506251/000121390024099649/ea0221547-8k_citius.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-099649

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer